Discovery of Novel Enhancers of Isoniazid Toxicity in Mycobacterium tuberculosis

The number of effective first-line antibiotics for the treatment of Mycobacterium tuberculosis infection is strongly limited to a few drugs. Due to emerging resistance against those drugs, second- and third-line antibiotics have been established in therapy with certain problems and also increasing m...

Descripción completa

Detalles Bibliográficos
Autores principales: Lentz, Fabian, Reiling, Norbert, Martins, Ana, Molnár, Joseph, Hilgeroth, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017859/
https://www.ncbi.nlm.nih.gov/pubmed/29617279
http://dx.doi.org/10.3390/molecules23040825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6017859/
https://www.ncbi.nlm.nih.gov/pubmed/29617279
http://dx.doi.org/10.3390/molecules23040825

Ejemplares similares